Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
18.98
+0.67 (3.66%)
Nov 5, 2024, 3:49 PM EST - Market open

CRBP Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
229271477105353
Upgrade
Market Cap Growth
1298.78%93.01%-82.05%-26.60%-70.25%5.64%
Upgrade
Enterprise Value
8821-27-449307
Upgrade
Last Close Price
18.316.043.3218.4737.50163.80
Upgrade
PE Ratio
--0.59-0.33-1.66-0.88-4.88
Upgrade
PS Ratio
---87.4526.689.77
Upgrade
PB Ratio
1.68-3.870.421.122.3257.35
Upgrade
P/FCF Ratio
-16.07-0.74-0.37-1.60-1.05-7.29
Upgrade
P/OCF Ratio
-16.07-0.74-0.37-1.60-1.05-7.72
Upgrade
EV/Sales Ratio
----4.3712.548.48
Upgrade
EV/EBITDA Ratio
-9.62-0.470.790.07-0.41-4.01
Upgrade
EV/EBIT Ratio
-9.47-0.460.770.07-0.40-3.98
Upgrade
EV/FCF Ratio
-12.65-0.580.720.08-0.49-6.33
Upgrade
Debt / Equity Ratio
0.12-3.020.760.380.591.53
Upgrade
Debt / FCF Ratio
-0.49-0.58-0.67-0.55-0.27-0.19
Upgrade
Asset Turnover
---0.010.050.75
Upgrade
Quick Ratio
6.130.664.685.742.760.99
Upgrade
Current Ratio
6.180.744.765.892.891.09
Upgrade
Return on Equity (ROE)
-51.78%-341.98%-82.95%-79.80%-432.68%-424.29%
Upgrade
Return on Assets (ROA)
-25.68%-59.57%-25.02%-33.32%-101.37%-100.26%
Upgrade
Return on Capital (ROIC)
-28.95%-78.19%-28.32%-41.71%-175.01%-221.45%
Upgrade
Earnings Yield
-15.86%-166.93%-305.90%-59.19%-105.92%-20.24%
Upgrade
FCF Yield
-13.65%-135.11%-271.30%-62.56%-95.36%-13.72%
Upgrade
Buyback Yield / Dilution
-67.92%-3.76%-1.85%-57.23%-22.28%-12.10%
Upgrade
Total Shareholder Return
-67.92%-3.76%-1.85%-57.23%-22.28%-12.10%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.